The J.P. Morgan View Growth versus virus now, vaccine versus virus later –an update on a conflict and a hope Cross-asset strategy: The dominant macro narrative of the past several weeks hasn’t changed much, and neither has the pattern of uneven advances across and within global markets. The reality of a booming economy versus the threat of a spending retrenchment…
After an outside reversal trading day last Friday that found the Nasdaq going from up 1% to negative .23%...
“It’s not that optimism solves all of life’s problems; it is just that it can sometimes make the difference...
When you feel like giving up, realize that at that very moment, you are at the same fork in...
This week’s focus is likely to be centered on CPI and the Fed. To us, that is yesterday’s news;...
Weekly Warm-up: More on The Mid Cycle Transition to Quality; Staples over Discretionary Last week we argued for a...
Welcome back to our weekly Research Report cycle (3-weeks on, 1 week off). The markets are expressing a very...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
